Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

3.28
Delayed Data
As of Aug 17
 0.00 / 0.00%
Today’s Change
2.61
Today|||52-Week Range
9.76
-44.03%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close3.28
Today’s openn.a.
Day’s range-- - --
Volume27
Average volume (3 months)9,708
Market cap$15.9M
Dividend yield--
Data as of 08/17/2017

Growth & Valuation

Earnings growth (last year)+17.60%
Earnings growth (this year)+6.02%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.35

Competitors

 Today’s
change
Today’s
% change
EYEGEyeGate Pharmaceutic...+0.09+9.68%
ONTXOnconova Therapeutic...+0.04+2.56%
OGENOragenics Inc+0.01+4.18%
IMRNImmuron Ltd-0.45-7.89%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
James Garner
Director-Finance &
Administration
Gabrielle Heaton
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts